Sepsis & infection

Serum proteomes and their prognostic values in sepsis patients admitted to a medical intensive care unit: a single-center study using SWATH-MS proteomics

Ann Intensive CarePublished Retrospective cohort study

Authors' conclusion

A novel set of biomarkers was identified in this study, including ACTB, FINC, CXCL7, TIMP1, and PF4, for assessing sepsis prognosis. The six-variable model incorporating SOFA scores demonstrated a high prognostic value for in-hospital mortality

Study context

Population
Adults with bacterial sepsis admitted to a medical ICU at a single tertiary hospital, January 2011–January 2020
Participants
217 vs 292
Exposure
Sepsis vs Healthy controls
  • Sepsisn = 217
  • Healthy controlsn = 292reference
Outcome
Serum proteomic biomarkers for assessing sepsis severity and predicting outcomes (in-hospital mortality)
Methodological detailssingle-centre, SWATH-MS proteomics
  • Single-centre
  • SWATH-MS proteomics

Main finding

As reported in the abstract

Discrimination of sepsis subgroups and prediction of in-hospital mortality
5 proteins (ACTB, fibronectin (FINC), TIMP1, PF4, CXCL7) discriminated sepsis subgroups, AUC range
0.786 to 0.833
Six-variable model (5 proteins + SOFA score) for in-hospital mortality, AUC
0.903
Decreased FINC, in-hospital mortality (multivariable Cox), HR 0.88 (0.79-0.98)
p = 0.024
Higher SOFA scores, in-hospital mortality (multivariable Cox), HR 1.08 (1.03-1.13)
p = 0.002
Gram-negative sepsis, in-hospital mortality (multivariable Cox), HR 1.42 (1.02-1.97)
p = 0.038

Observational data: associations, not effects.

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Serum proteomes and their prognostic values in sepsis patients admitted to a medical intensive care unit: a single-center study using SWATH-MS proteomics. Ann Intensive Care. Published 27 August 2025. doi:10.1186/s13613-025-01543-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.